Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Phase 3 crawled time : 15:40 save search
Iterum Therapeutics Announces Topline Results from its Phase 3 Clinical Trial of Oral Sulopenem for the Treatment of Uncomplicated Urinary Tract Infections
Published: 2020-06-29 (Crawled : 15:40) - globenewswire.com
ITRM | $1.58 10.06% 36K
|
Health Technology
|
| O: -4.58%
H: 0.68%
C: -2.74%
results phase 3 trial sulopenem treatment topline injection infections
Iterum Therapeutics to Present Data from Phase 3 Trials in Uncomplicated and Complicated Urinary Tract Infections at IDWeek 2020
Published: 2020-10-19 (Crawled : 15:40) - globenewswire.com
ITRM | $1.58 10.06% 36K
|
Health Technology
|
| O: 27.76%
H: 27.07%
C: 5.89%
phase 3 trial injection infections
UPDATE -- Iterum Therapeutics to Present Data from Phase 3 Trials in Uncomplicated and Complicated Urinary Tract Infections at IDWeek 2020
Published: 2020-10-19 (Crawled : 15:40) - globenewswire.com
ITRM | $1.58 10.06% 36K
|
Health Technology
|
| O: 27.76%
H: 27.07%
C: 5.89%
phase 3 trial injection infections
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.